Found: 31
Select item for more details and to access through your institution.
Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. e77, doi. 10.1111/bjh.17029
- By:
- Publication type:
- Article
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 233, doi. 10.1111/bjh.13035
- By:
- Publication type:
- Article
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13035
- By:
- Publication type:
- Article
SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 4, p. 504, doi. 10.1111/bjh.12778
- By:
- Publication type:
- Article
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1and CBLMutations Are Present in Systemic Mastocytosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043090
- By:
- Publication type:
- Article
Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2011, v. 1, n. 1, p. 19
- By:
- Publication type:
- Article
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62345-9
- By:
- Publication type:
- Article
Recent advances and novel treatment paradigms in acute lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 252, doi. 10.1177/2040620716652289
- By:
- Publication type:
- Article
Ribosomal S6 Kinase and AKT Phosphorylation as Pharmacodynamic Biomarkers in Patients With Myelodysplastic Syndrome Treated With RAD001.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 473, doi. 10.3816/CLML.2010.n.082
- By:
- Publication type:
- Article
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 288, doi. 10.1111/j.1600-0609.2012.01825.x
- By:
- Publication type:
- Article
Survival and Predictors of Outcome in Patients With Acute Leukemia Admitted to the Intensive Care Unit.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 10, p. 2233, doi. 10.1002/cncr.23394
- By:
- Publication type:
- Article
Barriers to the participation of African-American patients with cancer in clinical trials.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 6, p. 1499, doi. 10.1002/cncr.11213
- By:
- Publication type:
- Article
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e836, doi. 10.1016/j.clml.2022.04.022
- By:
- Publication type:
- Article
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Perspectives and Future Directions for Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00345-8
- By:
- Publication type:
- Article
Novel Therapies in Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 4, p. 289, doi. 10.1007/s11899-018-0457-7
- By:
- Publication type:
- Article
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 408, doi. 10.1002/ajh.25394
- By:
- Publication type:
- Article
Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. 862, doi. 10.1002/ajh.23755
- By:
- Publication type:
- Article
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 906, doi. 10.1002/ajh.23530
- By:
- Publication type:
- Article
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 10, p. 957, doi. 10.1002/ajh.23279
- By:
- Publication type:
- Article
Blinatumomab: A Novel Agent to Treat Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2011, v. 9, n. 10, p. 776
- By:
- Publication type:
- Article
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 4, p. 504, doi. 10.1111/j.1365-2141.2011.08607.x
- By:
- Publication type:
- Article
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 430, doi. 10.1111/j.1365-2141.2010.08387.x
- By:
- Publication type:
- Article
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 901, doi. 10.1093/oncolo/oyad114
- By:
- Publication type:
- Article
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 21, p. 3631, doi. 10.1002/cncr.35505
- By:
- Publication type:
- Article
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 905, doi. 10.1002/cncr.33321
- By:
- Publication type:
- Article
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.
- Published in:
- BMC Cancer, 2010, v. 10, p. 387, doi. 10.1186/1471-2407-10-387
- By:
- Publication type:
- Article